Today Thank you to everyone that add clarity to the confusion. I truly appreciate the time and effort.
One thing that I wish we could see is where the patients are being tested, and which sites are showing the best results. I'm sure Dr. Mad. is carefully looking into the protocols. She is 1 of 2 great highlights of 2021.
With the "optimized treatment" data and performance time lines performing well above Keytruda data (not to mention the possible adverse side effects), the SP may not rise as fast as it retreated today, but it will get back to new highs somtime in June. If not before then, should we see BTD. IMO.
With the number of treatments, safety profile, and current/pending results - I'm very surprised that the sp is where it is. I'm not the fist to say this today, but big pharma is taking notice. The artificially low sp is speaking.
Another 90 days of hope for the next patients and those in program.
Good luck to all.
Regards,BK